1. Arbutus Biopharma Corp
  2. Arbutus Biopharma Corp Ownership

Historical shareholding details of Bridge Builder Small/Mid Cap Growth Fund holdings in Arbutus Biopharma Corp (ABUS)

Monthly changes of Bridge Builder Small/Mid Cap Growth Fund shareholding in Arbutus Biopharma Corp over the previous months

Month Name Total no. shares held Percent Holding
Aug 31, 2025 Bridge Builder Small/Mid Cap Growth Fund 28,606 0.01%
Jul 31, 2025 Bridge Builder Small/Mid Cap Growth Fund 28,606 0.01%
Jun 30, 2025 Bridge Builder Small/Mid Cap Growth Fund 30,051 0.02%
May 31, 2025 Bridge Builder Small/Mid Cap Growth Fund 28,281 0.01%
Apr 30, 2025 Bridge Builder Small/Mid Cap Growth Fund 28,281 0.01%
Mar 31, 2025 Bridge Builder Small/Mid Cap Growth Fund 26,680 0.01%
Feb 28, 2025 Bridge Builder Small/Mid Cap Growth Fund 26,680 0.01%
Jan 31, 2025 Bridge Builder Small/Mid Cap Growth Fund 26,680 0.01%
Dec 31, 2024 Bridge Builder Small/Mid Cap Growth Fund 26,680 0.01%
Nov 30, 2024 Bridge Builder Small/Mid Cap Growth Fund 26,680 0.01%
Oct 31, 2024 Bridge Builder Small/Mid Cap Growth Fund 26,680 0.01%
Sep 30, 2024 Bridge Builder Small/Mid Cap Growth Fund 25,378 0.01%
Aug 31, 2024 Bridge Builder Small/Mid Cap Growth Fund 25,378 0.01%
Jul 31, 2024 Bridge Builder Small/Mid Cap Growth Fund 25,378 0.01%
Jun 30, 2024 Bridge Builder Small/Mid Cap Growth Fund 15,426 0.01%
May 31, 2024 Bridge Builder Small/Mid Cap Growth Fund 15,426 0.01%
Apr 30, 2024 Bridge Builder Small/Mid Cap Growth Fund 15,426 0.01%
Mar 31, 2024 Bridge Builder Small/Mid Cap Growth Fund 15,426 0.01%
Feb 29, 2024 Bridge Builder Small/Mid Cap Growth Fund 13,372 0.01%
Jan 31, 2024 Bridge Builder Small/Mid Cap Growth Fund 13,372 0.01%
Nov 30, 2023 Bridge Builder Small/Mid Cap Growth Fund 13,372 0.01%
Oct 31, 2023 Bridge Builder Small/Mid Cap Growth Fund 13,372 0.01%
Aug 31, 2023 Bridge Builder Small/Mid Cap Growth Fund 13,372 0.01%
Jul 31, 2023 Bridge Builder Small/Mid Cap Growth Fund 13,372 0.01%
May 31, 2023 Bridge Builder Small/Mid Cap Growth Fund 9,447 0.01%

View all ownership details of Arbutus Biopharma Corp